Top

Annals of Hematology

Published in:

01-03-2019 | ECMO | Letter to the Editor

Management of an adult patient with sickle cell disease and acute chest syndrome by veno-venous extracorporeal membrane oxygenation

Authors: O. Al-Sawaf, P. Köhler, D. A. Eichenauer, B. Böll, M. Kochanek, A. Shimabukuro-Vornhagen

Published in: Annals of Hematology | Issue 3/2019

Excerpt

Dear Editor, …

Piel FB, Steinberg MH, Rees DC (2017) Sickle cell disease. N Engl J Med 376(16):1561–1573CrossRefPubMed

Vichinsky EP, Neumayr LD, Earles AN, Williams R, Lennette ET, Dean D, Nickerson B, Orringer E, McKie V, Bellevue R, Daeschner C, Manci EA (2000) Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N Engl J Med 342(25):1855–1865CrossRefPubMed

Combes A, Hajage D, Capellier G, Demoule A, Lavoue S, Guervilly C, Da Silva D, Zafrani L, Tirot P, Veber B, Maury E, Levy B, Cohen Y, Richard C, Kalfon P, Bouadma L, Mehdaoui H, Beduneau G, Lebreton G, Brochard L, Ferguson ND, Fan E, Slutsky AS, Brodie D, Mercat A, Eolia Trial Group R, Ecmonet (2018) Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. N Engl J Med 378(21):1965–1975CrossRef

Peek GJ, Mugford M, Tiruvoipati R, Wilson A, Allen E, Thalanany MM, Hibbert CL, Truesdale A, Clemens F, Cooper N, Firmin RK, Elbourne D (2009) Collaboration Ct. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet 374(9698):1351–1363CrossRefPubMed

Hoffmann M, Geldner G, Leschke M (2011) Life-threatening acute chest syndrome with hemolytic crisis in sickle cell disease. Treatment using a venovenous extracorporeal membrane oxygenation (ECMO). Dtsch Med Wochenschr 136(43):2192–2195CrossRefPubMed

Parhar K, Parizkova B, Jones N, Valchanov K, Fowles JA, Besser M, Telfer P, Kaya B, Vuylsteke A, Rubino A (2016) Extracorporeal membrane oxygenation for the treatment of adult sickle cell acute chest syndrome. Perfusion 31(3):262–265CrossRefPubMed

Sewaralthahab SS, Menaker J, Law JY (2018) Successful use of veno-venous extracorporeal membrane oxygenation in an adult patient with sickle cell anemia and severe acute chest syndrome. Hemoglobin 42(1):65–67CrossRefPubMed

Ansari J, Moufarrej YE, Pawlinski R, Gavins FNE (2018) Sickle cell disease: a malady beyond a hemoglobin defect in cerebrovascular disease. Expert Rev Hematol 11(1):45–55CrossRefPubMed

Title: Management of an adult patient with sickle cell disease and acute chest syndrome by veno-venous extracorporeal membrane oxygenation
Authors: O. Al-Sawaf
P. Köhler
D. A. Eichenauer
B. Böll
M. Kochanek
A. Shimabukuro-Vornhagen
Publication date: 01-03-2019
Publisher: Springer Berlin Heidelberg
Keywords: ECMO
ECMO
Published in: Annals of Hematology / Issue 3/2019
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI: https://doi.org/10.1007/s00277-019-03596-z

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Management of an adult patient with sickle cell disease and acute chest syndrome by veno-venous extracorporeal membrane oxygenation

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 3/2019

Detection of AML-specific mutations in pediatric patient plasma using extracellular vesicle–derived RNA

The risk of infections in multiple myeloma before and after the advent of novel agents: a 12-year survey

The anti-myeloma effects of the selective JAK1 inhibitor (INCB052793) alone and in combination in vitro and in vivo

Whole-body low-dose CT recognizes two distinct patterns of lytic lesions in multiple myeloma patients with different disease metabolism at PET/MRI

Structural modeling of a novel TERC variant in a patient with aplastic anemia and short telomeres

Correction to: Structural modeling of a novel TERC variant in a patient with aplastic anemia and short telomeres

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page